JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -8.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 137 | +4 | 47.53M | $11.43B | +7 | −2 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | — |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | — | −2 |
| Q2 2024 | 16 | — | 7.74M | $826.28M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.97M | — | $242.46M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.97M | — | $242.46M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Capital World Investors ✦ | 1.92M | +5.7% | $236.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.09M | -1.9% | $134.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.09M | -1.9% | $134.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 1.00M | -4.6% | $123.38M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 611.29K | -6.2% | $75.28M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 611.29K | -6.2% | $75.28M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 533.68K | -3.6% | $65.72M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 533.68K | -3.6% | $65.72M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 506.35K | -51.9% | $62.36M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 506.35K | -51.9% | $62.36M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 302.11K | +16.9% | $37.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 302.11K | +16.9% | $37.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 192.03K | +69.9% | $23.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 187.13K | -41.5% | $23.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 187.13K | -41.5% | $23.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 84.15K | -68.7% | $10.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 84.15K | -68.7% | $10.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 59.38K | Nuevo | $7.31M | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 59.38K | Nuevo | $7.31M | 0.0% | New | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 38.18K | +2.8% | $4.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 15.09K | -28.2% | $1.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $7.31M | 0.0% |
| Marshall Wace | $7.31M | 0.0% |
Posición cerrada
| Arrowstreet Capital | $8.50M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 568 tenedores, 63.82M acciones, $11.28B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.